Tag Archives: Hamamatsu Photonics

November 2022—Hamamatsu Photonics announced that the FDA granted 510(k) clearance to market the NanoZoomer S360MD high-throughput, automated slide scanner system for primary diagnostic use. It is intended to aid pathologists in reviewing and interpreting digital images of surgical pathology slides prepared from formalin-fixed, paraffin-embedded tissue.

Oct. 18, 2022—Indica Labs and Hamamatsu Photonics announced an agreement to maintain long-term interoperability between Indica Labs’ Halo AP software platform and Hamamatsu’s NanoZoomer series of scanners.

Oct. 10, 2022—Hamamatsu Photonics announced that the FDA granted 510(k) clearance to market the NanoZoomer S360MD high-throughput, automated slide scanner system for primary diagnostic use.